Company Isis Pharm Med Srl with Fiscal Code 5790342
recorded a turnover of 2024 of
631.993,
with a net profit of
3.808
and having an average number of employees of
8.
The company operates in the field of Comerţ cu amănuntul al produselor farmaceutice having the NACE code 4773.
Sales - Ron
Sales, Profit, Employees, Total Income, Financial Results -
Isis Pharm Med Srl
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Sales - EUR
451.983
510.523
589.460
680.078
702.919
787.081
717.267
765.113
718.963
631.993
Total Income - EUR
467.419
512.464
593.867
682.546
704.491
787.091
719.099
809.332
724.921
632.002
Total Expenses - EUR
419.601
502.908
575.168
663.707
689.600
755.478
676.727
775.496
717.271
623.277
Gross Profit/Loss - EUR
47.818
9.556
18.699
18.839
14.891
31.613
42.372
33.836
7.650
8.725
Net Profit/Loss - EUR
39.161
6.696
13.966
12.014
7.857
24.289
37.330
26.649
3.527
3.808
Employees
8
11
11
13
13
13
13
13
11
8
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded.
In the last year of activity, the sales decreased by -11.6%, from 718.963 euro in the year 2023, to 631.993 euro in 2024.
The Net Profit increased by 301 euro, from 3.527 euro in 2023, to 3.808 in the last year.
Check the financial reports for the company - Isis Pharm Med Srl
Financial Rating - ISIS PHARM MED SRL
See the company's note based on the submitted financial data, relative to the industry of which it is a part.
Financial Rating
Payment Limits - Isis Pharm Med Srl
See the company's payment capacity for situations in which you conclude contracts with payment terms.
Check Payment Limits
Prob. of insolvency - Isis Pharm Med Srl
It determines the risk of insolvency based on the submitted accounting balance.
Insolvency Probability
Financial Reports - Isis Pharm Med Srl
Check all the financial reports of the company and know the risks in collaboration with it.
Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
Debts, Equity, Inventories, Receivables, Accounts, Assets -
Isis Pharm Med Srl - CUI 5790342
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Fixed Assets
78.179
88.524
84.346
80.439
75.399
74.228
76.397
75.867
70.414
15.000
Current Assets
174.239
182.020
188.570
226.909
259.359
290.347
290.145
288.559
236.565
254.850
Inventories
60.475
99.003
111.726
103.424
140.047
132.028
140.821
100.201
82.159
95.582
Receivables
38.895
22.892
66.708
107.854
93.059
139.475
128.466
156.319
133.209
152.747
Cash
74.869
60.125
10.136
15.631
26.253
18.844
20.858
32.040
21.197
6.522
Shareholders Funds
36.766
36.714
45.630
56.314
63.080
80.732
101.376
57.901
61.253
12.965
Social Capital
84
84
82
81
79
78
76
76
76
75
Debts
215.652
233.830
227.286
251.034
271.678
283.842
265.165
306.525
245.725
256.885
Income in Advance
0
0
0
0
0
0
0
0
0
0
Exchange rate - RON
4.9743
4.9465
4.9315
4.9468
4.8371
4.7454
4.6535
4.5681
4.4908
4.445
Main CAEN
"4773 - 4773"
CAEN Financial Year
4773
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
254.850 euro in 2024 which includes Inventories of
95.582 euro, Receivables of
152.747 euro and cash availability of
6.522 euro.
The company's Equity was valued at
12.965 euro, while total Liabilities amounted to
256.885 euro.
Equity decreased by -47.946 euro, from 61.253 euro in 2023, to 12.965 in 2024.
Similar services useful for checking companies and business development.
SellNet
Get the contact details for any company and get in touch with it.
Sectoral Studies
Knows the market and develops its own development strategies according to sectorial data.
Databases
Export in excel files the data of the companies selected according to the desired criteria.
Import - Export
Find importers and exporters according to the type of activity and the countries in which they carry it out.
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - Isis Pharm Med Srl